Sertraline Hydrochloride Tablet, Film Coated
Product Images NDC 71610-435

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Sertraline Hydrochloride (NDC 71610-435). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 100 mg (71610 0435 45)

Bottle Label 100 mg (71610 0435 45)
Label for Sertraline Hydrochloride 100 mg film-coated tablets, quantity 45, oral route, manufactured by Aurobindo Pharma Limited and repackaged by Aphena Pharma Solutions - Tennessee, LLC in Cookeville, TN. Includes storage instructions and a barcode.*
FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Chemical Structure (Sertraline Str)

Chemical Structure (Sertraline Str)
Chemical structure of sertraline hydrochloride showing the molecular arrangement including chlorinated phenyl rings and a methylammonium hydrochloride group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.